BR9203959A - Peptideos ciclicos,processo para sua preparacao,composicao farmaceutica,uso e processo para tratar desordens constritivas bronco-traqueais - Google Patents
Peptideos ciclicos,processo para sua preparacao,composicao farmaceutica,uso e processo para tratar desordens constritivas bronco-traqueaisInfo
- Publication number
- BR9203959A BR9203959A BR929203959A BR9203959A BR9203959A BR 9203959 A BR9203959 A BR 9203959A BR 929203959 A BR929203959 A BR 929203959A BR 9203959 A BR9203959 A BR 9203959A BR 9203959 A BR9203959 A BR 9203959A
- Authority
- BR
- Brazil
- Prior art keywords
- cyclic
- disorders
- peptide
- peptideos
- bronco
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 230000002227 vasoactive effect Effects 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/17—Vasoactive intestinal peptides; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/27—Cyclic peptide or cyclic protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77374791A | 1991-10-11 | 1991-10-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9203959A true BR9203959A (pt) | 1993-04-27 |
Family
ID=25099195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR929203959A BR9203959A (pt) | 1991-10-11 | 1992-10-13 | Peptideos ciclicos,processo para sua preparacao,composicao farmaceutica,uso e processo para tratar desordens constritivas bronco-traqueais |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5677419A (enExample) |
| EP (1) | EP0536741B1 (enExample) |
| JP (1) | JP2515473B2 (enExample) |
| KR (1) | KR970001580B1 (enExample) |
| CN (3) | CN1034943C (enExample) |
| AT (1) | ATE132165T1 (enExample) |
| AU (1) | AU656230B2 (enExample) |
| BG (1) | BG61125B2 (enExample) |
| BR (1) | BR9203959A (enExample) |
| CA (1) | CA2080272C (enExample) |
| CZ (1) | CZ281818B6 (enExample) |
| DE (1) | DE69207138T2 (enExample) |
| DK (1) | DK0536741T3 (enExample) |
| ES (1) | ES2082317T3 (enExample) |
| FI (2) | FI111646B (enExample) |
| GR (1) | GR3019326T3 (enExample) |
| HU (2) | HUT62606A (enExample) |
| IL (3) | IL103396A (enExample) |
| MX (1) | MX9205822A (enExample) |
| NO (3) | NO304523B1 (enExample) |
| NZ (1) | NZ244644A (enExample) |
| RU (1) | RU2095368C1 (enExample) |
| SK (1) | SK279399B6 (enExample) |
| TW (1) | TW305846B (enExample) |
| UY (2) | UY23488A1 (enExample) |
| ZA (1) | ZA927724B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872803B1 (en) | 1993-09-21 | 2005-03-29 | Kyowa Hakko Kogyo Co., Ltd. | Peptides |
| BR9707409A (pt) * | 1996-02-09 | 1999-04-13 | Waleed Danho | Sintese de análogo de vip |
| ATE380038T1 (de) * | 1996-07-12 | 2007-12-15 | Immunomedics Inc | Radiometall-bindende peptide analoge |
| WO1998002453A2 (en) * | 1996-07-15 | 1998-01-22 | Universite Libre De Bruxelles | Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| DE60039111D1 (de) * | 1999-09-28 | 2008-07-17 | Bayer Corp | Agonisten des rezeptors 3 (r3) von pituitary adenylate cyclase aktivierendem peptid (pacap) und ihre pharmakologische verwendung |
| US6972319B1 (en) | 1999-09-28 | 2005-12-06 | Bayer Pharmaceuticals Corporation | Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use |
| AU2000265051A1 (en) * | 2000-02-18 | 2001-08-27 | Dabur Research Foundation | Vasoactive intestinal peptide analogs |
| DE60033697D1 (de) | 2000-02-18 | 2007-04-12 | Dabur Res Foundation Sahibabad | Radiomarkierte vip-analoge zur diagnose und therapie |
| US6828304B1 (en) | 2000-07-31 | 2004-12-07 | Dabur Research Foundation | Peptides for treatment of cancer |
| US7507714B2 (en) * | 2000-09-27 | 2009-03-24 | Bayer Corporation | Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use |
| WO2002043746A2 (en) | 2000-11-28 | 2002-06-06 | Mondobiotech Sa | Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| JP2005535607A (ja) | 2002-06-10 | 2005-11-24 | モンドバイオテック・ラボラトリーズ・アンスタルト | サルコイドーシスを治療するための血管作動性腸管ペプチドの生物活性をもつ化合物の使用 |
| JP2007519739A (ja) * | 2004-01-27 | 2007-07-19 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 下垂体細胞アデニル酸シクラーゼ活性化ペプチド（ｐａｃａｐ）受容体（ｖｃａｐ２）アゴニストおよびそれらの製薬学的使用方法 |
| WO2006023367A1 (en) * | 2004-08-18 | 2006-03-02 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| US20080085860A1 (en) * | 2004-08-18 | 2008-04-10 | Eli Lilly And Company | Selective Vpac2 Receptor Peptide Agonists |
| RU2304146C2 (ru) * | 2005-10-17 | 2007-08-10 | Закрытое акционерное общество "Эпитек" | Способ стабилизации петлеобразной структуры синтетических пептидов с помощью n- и c-концевых модификаций |
| JP2009528376A (ja) * | 2006-02-28 | 2009-08-06 | イーライ リリー アンド カンパニー | 選択的ｖｐａｃ２受容体ペプチドアゴニスト |
| BRPI0714306A2 (pt) * | 2006-07-06 | 2014-05-20 | Hoffmann La Roche | Análogos do peptídio intestinal vasoativo |
| CN101906144B (zh) * | 2009-06-03 | 2013-06-19 | 首都医科大学 | 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用 |
| IN2012DN02120A (enExample) | 2009-08-14 | 2015-08-21 | Phasebio Pharmaceuticals Inc | |
| CA2797033C (en) | 2010-04-22 | 2021-10-19 | Longevity Biotech, Inc. | Highly active polypeptides and methods of making and using the same |
| ES2669190T3 (es) | 2011-06-06 | 2018-05-24 | Phasebio Pharmaceuticals, Inc. | Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión |
| WO2014145718A2 (en) | 2013-03-15 | 2014-09-18 | Longevity Biotech, Inc. | Peptides comprising non-natural amino acids and methods of making and using the same |
| GB201421647D0 (en) * | 2014-12-05 | 2015-01-21 | Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |
| ES2822598T3 (es) | 2015-02-09 | 2021-05-04 | Phasebio Pharmaceuticals Inc | Métodos y composiciones para tratar enfermedades y trastornos musculares |
| CA3036768A1 (en) | 2016-09-30 | 2018-04-05 | Fujifilm Corporation | Cyclic peptide, affinity chromatography support, labeled antibody, antibody drug conjugate, and pharmaceutical preparation |
| IL295797A (en) * | 2020-02-22 | 2022-10-01 | Japan Chem Res | Human transfer receptor binding peptide |
| WO2023026994A1 (ja) * | 2021-08-21 | 2023-03-02 | 武田薬品工業株式会社 | ヒトトランスフェリンレセプター結合ペプチド－薬物コンジュゲート |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8427651D0 (en) * | 1984-11-01 | 1984-12-05 | Beecham Group Plc | Compounds |
| US4835252A (en) * | 1987-02-26 | 1989-05-30 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Vasoactive intestinal peptide analogs |
| GB8729802D0 (en) * | 1987-12-22 | 1988-02-03 | Beecham Group Plc | Novel compounds |
| US5084442A (en) * | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
| US5141924A (en) * | 1989-06-30 | 1992-08-25 | Hoffmann-La Roche, Inc. | Synthetic vasoactive intestinal peptide analogs |
-
1992
- 1992-10-06 AU AU26228/92A patent/AU656230B2/en not_active Ceased
- 1992-10-07 ZA ZA927724A patent/ZA927724B/xx unknown
- 1992-10-07 NZ NZ244644A patent/NZ244644A/en unknown
- 1992-10-08 EP EP92117185A patent/EP0536741B1/en not_active Expired - Lifetime
- 1992-10-08 AT AT92117185T patent/ATE132165T1/de not_active IP Right Cessation
- 1992-10-08 DE DE69207138T patent/DE69207138T2/de not_active Expired - Lifetime
- 1992-10-08 ES ES92117185T patent/ES2082317T3/es not_active Expired - Lifetime
- 1992-10-08 DK DK92117185.6T patent/DK0536741T3/da active
- 1992-10-08 RU SU925053217A patent/RU2095368C1/ru active
- 1992-10-08 TW TW081107995A patent/TW305846B/zh active
- 1992-10-09 IL IL103396A patent/IL103396A/xx not_active IP Right Cessation
- 1992-10-09 NO NO923929A patent/NO304523B1/no not_active IP Right Cessation
- 1992-10-09 MX MX9205822A patent/MX9205822A/es not_active IP Right Cessation
- 1992-10-09 CZ CS923086A patent/CZ281818B6/cs not_active IP Right Cessation
- 1992-10-09 IL IL11725292A patent/IL117252A/xx not_active IP Right Cessation
- 1992-10-09 JP JP4297835A patent/JP2515473B2/ja not_active Expired - Fee Related
- 1992-10-09 HU HU9203194A patent/HUT62606A/hu unknown
- 1992-10-09 CA CA002080272A patent/CA2080272C/en not_active Expired - Fee Related
- 1992-10-09 UY UY23488A patent/UY23488A1/es not_active IP Right Cessation
- 1992-10-09 FI FI924580A patent/FI111646B/fi active
- 1992-10-09 SK SK3086-92A patent/SK279399B6/sk unknown
- 1992-10-10 KR KR1019920018660A patent/KR970001580B1/ko not_active Expired - Fee Related
- 1992-10-10 CN CN92113069A patent/CN1034943C/zh not_active Expired - Fee Related
- 1992-10-13 BR BR929203959A patent/BR9203959A/pt not_active Application Discontinuation
-
1994
- 1994-02-28 BG BG098608A patent/BG61125B2/bg unknown
- 1994-09-19 US US08/308,729 patent/US5677419A/en not_active Expired - Lifetime
-
1995
- 1995-06-21 HU HU95P/P00297P patent/HU211534A9/hu unknown
-
1996
- 1996-02-23 IL IL11725296A patent/IL117252A0/xx unknown
- 1996-03-15 GR GR960400712T patent/GR3019326T3/el unknown
- 1996-08-15 CN CNB961118075A patent/CN1225473C/zh not_active Expired - Fee Related
- 1996-08-15 CN CNB961115238A patent/CN1198841C/zh not_active Expired - Fee Related
-
1997
- 1997-10-31 NO NO975023A patent/NO975023D0/no not_active Application Discontinuation
-
1998
- 1998-01-28 NO NO980377A patent/NO980377D0/no unknown
- 1998-07-06 UY UY25084A patent/UY25084A1/es unknown
-
2000
- 2000-09-15 FI FI20002041A patent/FI20002041A7/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9205822A (es) | Peptido ciclico, procedimiento para su preparacion y composicion farmaceutica que lo contiene | |
| EP0662827A4 (en) | THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS BASED ON NOTCH PROTEINS AND NUCLEIC ACIDS. | |
| IL142025A0 (en) | Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds | |
| ATE173275T1 (de) | Von einem retrovirus aus der hiv-gruppe abgeleitete peptide und deren verwendung | |
| DK601786A (da) | Hidtil ukendte prokoagulationsproteiner | |
| EP0498784A3 (en) | Inhibitors of retroviral protease | |
| MX167236B (es) | Peptidos sinteticos de timosina -1 y metodo para su obtencion | |
| EP0333587A3 (en) | Method for purifying and isolating carboxyl-terminal peptides | |
| GR3020185T3 (en) | Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides | |
| AU6393990A (en) | Hiv related peptides | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| TW370615B (en) | Method and kit for simultaneously detecting antibodies of HIV-1 and HIV-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EE | Request for examination | ||
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal | ||
| CKFC | Appeal: appeal against refusal | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: C07K 14/575 (2006.01), A61K 38/00 (2006.0 |